TY  - GEN
AU  - Yu,Helena A
AU  - Arcila,Maria E
AU  - Rekhtman,Natasha
AU  - Sima,Camelia S
AU  - Zakowski,Maureen F
AU  - Pao,William
AU  - Kris,Mark G
AU  - Miller,Vincent A
AU  - Ladanyi,Marc
AU  - Riely,Gregory J
TI  - Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers
SN  - 1557-3265
PY  - 2013///1111
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biopsy
KW  - CD56 Antigen
KW  - analysis
KW  - DNA Mutational Analysis
KW  - methods
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Gefitinib
KW  - Humans
KW  - Immunohistochemistry
KW  - In Situ Hybridization, Fluorescence
KW  - Kaplan-Meier Estimate
KW  - Ki-67 Antigen
KW  - Lung
KW  - drug effects
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Proto-Oncogene Proteins c-met
KW  - Quinazolines
KW  - Receptor, ErbB-2
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1158/1078-0432.CCR-12-2246
ER  -